Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Kidney Cancer
Related studies linked through entity extraction aliases.
Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial
- Status
- COMPLETED
- Phase
- PHASE2
S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy
- Status
- COMPLETED
- Phase
- N/A
Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain
- Status
- COMPLETED
- Phase
- PHASE2
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
- Status
- UNKNOWN
- Phase
- NA
Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Comparison of Immune Response Following Surgical Management of Renal Tumors
- Status
- TERMINATED
- Phase
- N/A
Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Bortezomib in Treating Patients With Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfaction.
- Status
- COMPLETED
- Phase
- N/A